Emerging aspects of Buruli ulcer.
- 1 July 2003
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 1 (2) , 217-222
- https://doi.org/10.1586/14787210.1.2.217
Abstract
Buruli ulcer, caused by the pathogen Mycobacterium ulcerans, is a major mycobacteriosis that affects people in scattered foci in the third world. It is amongst the most neglected of diseases in terms of primary healthcare strategies. However, this is changing as the World Health Organization launches a number of major global initiatives. Recent progress includes the unraveling of the genetic structure of the pathogen, examination of the mechanisms of virulence and the role of chemotherapy in disease treatment and prevention of recurrence, together with strategies aimed at reducing the economic burdens placed upon healthcare budgets of poorer nations. This review focuses upon the recent developments and the understanding of the disease, with particular focus on potential chemotherapy.Keywords
This publication has 12 references indexed in Scilit:
- Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulceransMicrobial Pathogenesis, 2003
- Mycobacterium ulcerans disease (Buruli ulcer) following human biteThe Lancet, 2002
- Buruli Ulcer in Ghana: Results of a National Case SearchEmerging Infectious Diseases, 2002
- Mycobacterium ulceransCytotoxicity in an Adipose Cell ModelInfection and Immunity, 2001
- Activities of Several Antimicrobials against Mycobacterium ulcerans Infection in MiceAntimicrobial Agents and Chemotherapy, 2000
- Identification of Mycobacterium ulcerans in the Environment from Regions in Southeast Australia in Which It Is Endemic with Sequence Capture-PCRApplied and Environmental Microbiology, 2000
- Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for VirulenceScience, 1999
- Socioeconomic implications of Buruli ulcer in Ghana: a three-year review.The American Journal of Tropical Medicine and Hygiene, 1998
- In Vitro Susceptibility of Mycobacterium ulcerans to ClarithromycinAntimicrobial Agents and Chemotherapy, 1998
- Effectiveness of Excision of Pre-Ulcerative Buruli Lesions in Field Situations in a Rural District in GhanaTropical Doctor, 1998